Cargando…
AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombination
Immunoglobulin class switch recombination (CSR) plays critical roles in controlling infections and inflammatory tissue injuries. Here, we show that AFF3, a candidate gene for both rheumatoid arthritis and type 1 diabetes, is a molecular facilitator of CSR with an isotype preference. Aff3-deficient m...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401627/ https://www.ncbi.nlm.nih.gov/pubmed/36001653 http://dx.doi.org/10.1126/sciadv.abq0008 |
_version_ | 1784773006060421120 |
---|---|
author | Tsukumo, Shin-ichi Subramani, Poorani Ganesh Seija, Noé Tabata, Mizuho Maekawa, Yoichi Mori, Yuya Ishifune, Chieko Itoh, Yasushi Ota, Mineto Fujio, Keishi Di Noia, Javier M. Yasutomo, Koji |
author_facet | Tsukumo, Shin-ichi Subramani, Poorani Ganesh Seija, Noé Tabata, Mizuho Maekawa, Yoichi Mori, Yuya Ishifune, Chieko Itoh, Yasushi Ota, Mineto Fujio, Keishi Di Noia, Javier M. Yasutomo, Koji |
author_sort | Tsukumo, Shin-ichi |
collection | PubMed |
description | Immunoglobulin class switch recombination (CSR) plays critical roles in controlling infections and inflammatory tissue injuries. Here, we show that AFF3, a candidate gene for both rheumatoid arthritis and type 1 diabetes, is a molecular facilitator of CSR with an isotype preference. Aff3-deficient mice exhibit low serum levels of immunoglobulins, predominantly immunoglobulin G2c (IgG2c) followed by IgG1 and IgG3 but not IgM. Furthermore, Aff3-deficient mice show weak resistance to Plasmodium yoelii infection, confirming that Aff3 modulates immunity to this pathogen. Mechanistically, the AFF3 protein binds to the IgM and IgG1 switch regions via a C-terminal domain, and Aff3 deficiency reduces the binding of AID to the switch regions less efficiently. One AFF3 risk allele for rheumatoid arthritis is associated with high mRNA expression of AFF3, IGHG2, and IGHA2 in human B cells. These findings demonstrate that AFF3 directly regulates CSR by facilitating the recruitment of AID to the switch regions. |
format | Online Article Text |
id | pubmed-9401627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-94016272022-08-26 AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombination Tsukumo, Shin-ichi Subramani, Poorani Ganesh Seija, Noé Tabata, Mizuho Maekawa, Yoichi Mori, Yuya Ishifune, Chieko Itoh, Yasushi Ota, Mineto Fujio, Keishi Di Noia, Javier M. Yasutomo, Koji Sci Adv Biomedicine and Life Sciences Immunoglobulin class switch recombination (CSR) plays critical roles in controlling infections and inflammatory tissue injuries. Here, we show that AFF3, a candidate gene for both rheumatoid arthritis and type 1 diabetes, is a molecular facilitator of CSR with an isotype preference. Aff3-deficient mice exhibit low serum levels of immunoglobulins, predominantly immunoglobulin G2c (IgG2c) followed by IgG1 and IgG3 but not IgM. Furthermore, Aff3-deficient mice show weak resistance to Plasmodium yoelii infection, confirming that Aff3 modulates immunity to this pathogen. Mechanistically, the AFF3 protein binds to the IgM and IgG1 switch regions via a C-terminal domain, and Aff3 deficiency reduces the binding of AID to the switch regions less efficiently. One AFF3 risk allele for rheumatoid arthritis is associated with high mRNA expression of AFF3, IGHG2, and IGHA2 in human B cells. These findings demonstrate that AFF3 directly regulates CSR by facilitating the recruitment of AID to the switch regions. American Association for the Advancement of Science 2022-08-24 /pmc/articles/PMC9401627/ /pubmed/36001653 http://dx.doi.org/10.1126/sciadv.abq0008 Text en Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited. |
spellingShingle | Biomedicine and Life Sciences Tsukumo, Shin-ichi Subramani, Poorani Ganesh Seija, Noé Tabata, Mizuho Maekawa, Yoichi Mori, Yuya Ishifune, Chieko Itoh, Yasushi Ota, Mineto Fujio, Keishi Di Noia, Javier M. Yasutomo, Koji AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombination |
title | AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombination |
title_full | AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombination |
title_fullStr | AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombination |
title_full_unstemmed | AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombination |
title_short | AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombination |
title_sort | aff3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombination |
topic | Biomedicine and Life Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401627/ https://www.ncbi.nlm.nih.gov/pubmed/36001653 http://dx.doi.org/10.1126/sciadv.abq0008 |
work_keys_str_mv | AT tsukumoshinichi aff3asusceptibilityfactorforautoimmunediseasesisamolecularfacilitatorofimmunoglobulinclassswitchrecombination AT subramanipooraniganesh aff3asusceptibilityfactorforautoimmunediseasesisamolecularfacilitatorofimmunoglobulinclassswitchrecombination AT seijanoe aff3asusceptibilityfactorforautoimmunediseasesisamolecularfacilitatorofimmunoglobulinclassswitchrecombination AT tabatamizuho aff3asusceptibilityfactorforautoimmunediseasesisamolecularfacilitatorofimmunoglobulinclassswitchrecombination AT maekawayoichi aff3asusceptibilityfactorforautoimmunediseasesisamolecularfacilitatorofimmunoglobulinclassswitchrecombination AT moriyuya aff3asusceptibilityfactorforautoimmunediseasesisamolecularfacilitatorofimmunoglobulinclassswitchrecombination AT ishifunechieko aff3asusceptibilityfactorforautoimmunediseasesisamolecularfacilitatorofimmunoglobulinclassswitchrecombination AT itohyasushi aff3asusceptibilityfactorforautoimmunediseasesisamolecularfacilitatorofimmunoglobulinclassswitchrecombination AT otamineto aff3asusceptibilityfactorforautoimmunediseasesisamolecularfacilitatorofimmunoglobulinclassswitchrecombination AT fujiokeishi aff3asusceptibilityfactorforautoimmunediseasesisamolecularfacilitatorofimmunoglobulinclassswitchrecombination AT dinoiajavierm aff3asusceptibilityfactorforautoimmunediseasesisamolecularfacilitatorofimmunoglobulinclassswitchrecombination AT yasutomokoji aff3asusceptibilityfactorforautoimmunediseasesisamolecularfacilitatorofimmunoglobulinclassswitchrecombination |